Cancer immunotherapy using T-cell receptor engineered T cell
Crossref DOI link: https://doi.org/10.21037/aob.2020.02.02
Published Online: 2020-03
Update policy: https://doi.org/10.21037/ame_crossmark_policy
Liu, Qi
Cai, Wenxuan
Zhang, Wei
Li, Yi